Taysha Gene Therapies Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +1,725,773.3% | -17.4% | -41.0% | +36.8% | -7.2% | +114.1% | |
| – | +1,719,093.3% | -38.1% | -39.6% | +55.4% | -5.2% | +128.4% | |
| – | – | -40.7% | -41.1% | +63.8% | -3.4% | +130.0% | |
| – | – | -40.7% | -41.1% | +63.8% | -3.4% | +130.0% | |
| – | – | +17,534.1% | – | – | – | – | |
| – | +4,952.7% | +1,464.5% | +5.7% | -22.0% | -9.2% | +8.5% | |
| – | +4,652.7% | +625.9% | +21.3% | -41.5% | -28.6% | +1.2% | |
| – | – | – | – | +8.2% | +14.0% | – | |
| – | – | +991.4% | -49.7% | -41.8% | -43.6% | +74.7% | |
| – | – | – | +2.1% | +6.7% | +8.5% | +14.0% | |
| – | – | -62.0% | -99.0% | +7,796.4% | -4.6% | +245.2% | |
| – | – | – | – | – | – | – | |
| – | -52.2% | +113.1% | +16.7% | +164.2% | +115.4% | +27.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.